StockNews.com initiated coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Free Report) in a research note published on Monday. The brokerage issued a hold rating on the biotechnology company’s stock. vTv Therapeutics Price Performance Shares of NASDAQ VTVT opened at $7.87 on Monday. The firm has a fifty day moving average price of $10.12 and […]
Related Keywords
, Pathstone Family Office , Millennium Management , Tv Therapeutics Inc , Tv Therapeutics Company Profile , Prudential Financial Inc , Free Report , Get Free Report , Family Office , Street Corp , Vtv Therapeutics , Nasdaq Vtvt , Vtvt , Medical , Initiated Coverage , Stocknews Com ,
comparemela.com © 2020. All Rights Reserved.